Reduced cytomegalovirus reactivation and viremia following unrelated donor peripheral blood stem cell transplantation (URD-PBSCT) with targeted anti-thymocyte globulin (ATG) dosing: A prospective study
Background: Anti-thymocyte globulin (ATG) is widely used in allogeneic hematopoietic stem cell transplantation (allo-HCT) to prevent severe graft-versus-host disease (GVHD) and graft failure. Insufficient ATG exposure may reduce its effectiveness in GVHD prophylaxis, while excessive exposure can ele...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2026-03-01
|
| シリーズ: | Cancer Pathogenesis and Therapy |
| 主題: | |
| オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2949713225000369 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
